OPKO Health, Inc. (OPK)

1.48 -1.33% (-0.02)

Over 5Y: -61.3%

2026-08-28
2 4
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 385.8M Q3 '21 — Operating Cash Flow: 33.4M Q3 '21 — Free Cash Flow: 26.2M Q3 '21 — Net Income: 28.7M Q4 '21 — Revenue: 401.3M Q4 '21 — Operating Cash Flow: -5.6M Q4 '21 — Free Cash Flow: -12.4M Q4 '21 — Net Income: -73.8M Q1 '22 — Revenue: 329.2M Q1 '22 — Operating Cash Flow: -19.9M Q1 '22 — Free Cash Flow: -25.1M Q1 '22 — Net Income: -55.4M Q2 '22 — Revenue: 309.9M Q2 '22 — Operating Cash Flow: -11.5M Q2 '22 — Free Cash Flow: -16.9M Q2 '22 — Net Income: -101.7M Q3 '22 — Revenue: 179.7M Q3 '22 — Operating Cash Flow: -32.2M Q3 '22 — Free Cash Flow: -39.8M Q3 '22 — Net Income: -86.1M Q4 '22 — Revenue: 185.3M Q4 '22 — Operating Cash Flow: -31.6M Q4 '22 — Free Cash Flow: -38M Q4 '22 — Net Income: -85.2M Q1 '23 — Revenue: 237.6M Q1 '23 — Operating Cash Flow: -22.6M Q1 '23 — Free Cash Flow: -25.7M Q1 '23 — Net Income: -18.3M Q2 '23 — Revenue: 265.4M Q2 '23 — Operating Cash Flow: -365K Q2 '23 — Free Cash Flow: -6.4M Q2 '23 — Net Income: -19.6M Q3 '23 — Revenue: 178.6M Q3 '23 — Operating Cash Flow: 33.1M Q3 '23 — Free Cash Flow: 28.9M Q3 '23 — Net Income: -84.5M Q4 '23 — Revenue: 181.9M Q4 '23 — Operating Cash Flow: -38.3M Q4 '23 — Free Cash Flow: -41.3M Q4 '23 — Net Income: -66.5M Q1 '24 — Revenue: 173.7M Q1 '24 — Operating Cash Flow: -35.6M Q1 '24 — Free Cash Flow: -40M Q1 '24 — Net Income: -81.8M Q2 '24 — Revenue: 182.2M Q2 '24 — Operating Cash Flow: -26.4M Q2 '24 — Free Cash Flow: -33.7M Q2 '24 — Net Income: -10.3M Q3 '24 — Revenue: 173.6M Q3 '24 — Operating Cash Flow: -77.1M Q3 '24 — Free Cash Flow: -85M Q3 '24 — Net Income: 24.9M Q4 '24 — Revenue: 183.6M Q4 '24 — Operating Cash Flow: -44.4M Q4 '24 — Free Cash Flow: -49.8M Q4 '24 — Net Income: 14M Q1 '25 — Revenue: 150M Q1 '25 — Operating Cash Flow: -34.6M Q1 '25 — Free Cash Flow: -37.7M Q1 '25 — Net Income: -67.6M Q2 '25 — Revenue: 156.8M Q2 '25 — Operating Cash Flow: -83.4M Q2 '25 — Free Cash Flow: -86.7M Q2 '25 — Net Income: -148.4M Q3 '25 — Revenue: 151.7M Q3 '25 — Operating Cash Flow: -34.6M Q3 '25 — Free Cash Flow: -37.8M Q3 '25 — Net Income: 21.6M Q4 '25 — Revenue: 148.5M Q4 '25 — Operating Cash Flow: -25.9M Q4 '25 — Free Cash Flow: -28.6M Q4 '25 — Net Income: -31.3M Q1 '26 — Revenue: 124.2M Q1 '26 — Operating Cash Flow: -19.3M Q1 '26 — Free Cash Flow: -21.1M Q1 '26 — Net Income: -54.8M Q2 '26 — Revenue: 163.6M Q2 '26 — Operating Cash Flow: -43.5M Q2 '26 — Free Cash Flow: -46.5M Q2 '26 — Net Income: -8.4M 0 150M 300M 450M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.5
OE margin -24.6%
Oper. margin -8.2%
ROIC -3.1%
Accruals 2.8%
Gross margin 40.8%
FCF margin -22.8%
OCF margin -21.0%
Profit margin -12.4%
ROA -4.0%
ROCE -2.9%
ROE -6.2%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.1
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.8
ND/EBITDA —
Net debt / Eq 0.032×
Quick ratio 2.9×
Cash / Debt 0.89×
Debt / Eq 0.3×
F-score 4.0 pts
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales CAGR 4Y -23.5%
Sales/sh Y/Y -18.2%
Sales Q/Q +4.3%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.